Gene · 2621
NIH grants2,018
NIH grants whose papers are about the gene, through NIH's grant-paper links.
501 to 520 of 2,018
Download this page as JSON| Grant | Title | GAS6 papers | Newest fiscal year |
|---|---|---|---|
| U24CA248457 | GenePattern and GenePattern Notebook: Integrative 'Omic Analysis for Cancer Research | 1 | 2024 |
| UL1TR001427 | Together: Transforming and Translating Discovery to Improve Health | 1 | 2024 |
| UL1TR002001 | The University of Rochester Clinical and Translational Science Award Hub | 1 | 2024 |
| P01HL120840 | Pannexin Channels In Vascular Physiology & Inflammation | 3 | 2023 |
| R01CA169338 | Rational Combined Inhibition of NF-kB and EGFR to Optimize Lung Cancer Treatment | 3 | 2023 |
| I01BX003368 | Molecular Regulation of Breast Cancer Progression | 2 | 2023 |
| KL2TR001421 | Institutional Career Development Core | 2 | 2023 |
| P01CA114046 | Targeted Therapies in Melanoma | 2 | 2023 |
| R01AI145044 | B-cell-specific transduction for anti-HIV antibody and B-cell receptor expression | 2 | 2023 |
| R01CA177909 | Platelets promote growth of ovarian cancer | 2 | 2023 |
| R01CA232256 | An integrated approach to melanoma metastasis and therapy resistance: effects of age-related changes in the ECM and the biomechanics of the skin | 2 | 2023 |
| R01GM136826 | Regulation of epithelial junctions and lumen morphogenesis by the Scribble/SGEF/Dlg1 complex | 2 | 2023 |
| R44CA250861 | Ultra-high content analyses of circulating and solid tumor cells: A diagnostic reference system for disease burden | 2 | 2023 |
| T32DK007467 | Research Training in Renal Disease | 2 | 2023 |
| T32GM007250 | Medical Scientist Training Program | 2 | 2023 |
| U19AI062629 | Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax | 2 | 2023 |
| UL1TR001420 | Wake Forest Clinical and Translational Science Award | 2 | 2023 |
| DP2CA259675 | Dissection of in situ myeloid signaling using image-guided synthetic control | 1 | 2023 |
| F30CA239390 | Role of cell-intrinsic effects of PD-L1 in carcinogenesis | 1 | 2023 |
| F30CA254215 | Targeting Rad18-dependent replication stress pathways to modulate chemoresponse in BRCA1-deficient cancers | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/grants?page=26